Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000517517 | SCV000613070 | likely benign | not provided | 2017-11-16 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000644478 | SCV000766176 | uncertain significance | Amyotrophic lateral sclerosis type 1; Perry syndrome; Neuronopathy, distal hereditary motor, type 7B | 2024-01-13 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 148 of the DCTN1 protein (p.Arg148Trp). This variant is present in population databases (rs148810193, gnomAD 0.01%). This missense change has been observed in individual(s) with amyotrophic lateral sclerosis (ALS) (PMID: 23143281). ClinVar contains an entry for this variant (Variation ID: 447238). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. Experimental studies have shown that this missense change does not substantially affect DCTN1 function (PMID: 23143281). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Baylor Genetics | RCV001329176 | SCV001520538 | uncertain significance | Neuronopathy, distal hereditary motor, type 7B | 2019-09-06 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Mayo Clinic Laboratories, |
RCV000517517 | SCV004224933 | uncertain significance | not provided | 2023-03-10 | criteria provided, single submitter | clinical testing |